The legacy success of sildenafil has undeniably shaped the drug landscape. However, investing in companies heavily reliant on biosimilars and the diminishing patent protection surrounding this iconic https://myfirstbookmark.com/story21408050/sildenafil-and-pharma-a-speculative-venture